HC Wainwright & Co. Maintains Buy on Tenaya Therapeutics, Lowers Price Target to $5

Benzinga · 03/11 10:31
HC Wainwright & Co. analyst Joseph Pantginis maintains Tenaya Therapeutics (NASDAQ:TNYA) with a Buy and lowers the price target from $18 to $5.